Weijun Liu

3.8k total citations · 1 hit paper
71 papers, 2.8k citations indexed

About

Weijun Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weijun Liu has authored 71 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 12 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Weijun Liu's work include MicroRNA in disease regulation (9 papers), Ubiquitin and proteasome pathways (7 papers) and RNA Interference and Gene Delivery (6 papers). Weijun Liu is often cited by papers focused on MicroRNA in disease regulation (9 papers), Ubiquitin and proteasome pathways (7 papers) and RNA Interference and Gene Delivery (6 papers). Weijun Liu collaborates with scholars based in China, United States and Japan. Weijun Liu's co-authors include Xiaowei Wang, Nathan Wong, Takeo Fujita, Yong Wan, William R. Jacobs, Daekyu Sun, Laurence H. Hurley, Hiroyoshi Doihara, Steven C. Almo and Juan Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Weijun Liu

63 papers receiving 2.7k citations

Hit Papers

Prediction of functional microRNA targets by integrative ... 2019 2026 2021 2023 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data
    2019 577 citations Weijun Liu, Xiaowei Wang profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijun Liu China 26 1.7k 697 363 321 298 71 2.8k
César López‐Camarillo Mexico 34 2.0k 1.2× 1.1k 1.6× 496 1.4× 258 0.8× 407 1.4× 160 3.4k
Liwei Dong China 35 1.6k 0.9× 686 1.0× 440 1.2× 402 1.3× 425 1.4× 102 3.2k
Jingwan Zhang Hong Kong 25 2.1k 1.2× 710 1.0× 644 1.8× 259 0.8× 203 0.7× 60 2.9k
Huizhe Huang China 24 1.4k 0.8× 397 0.6× 371 1.0× 251 0.8× 456 1.5× 50 2.5k
Ravindra Kolhe United States 32 1.6k 0.9× 726 1.0× 664 1.8× 191 0.6× 335 1.1× 147 3.4k
Ninghan Feng China 27 1.4k 0.8× 575 0.8× 401 1.1× 248 0.8× 115 0.4× 126 2.2k
Ke Shi China 27 1.1k 0.6× 469 0.7× 257 0.7× 293 0.9× 308 1.0× 142 2.5k
Ji Eun Oh South Korea 25 1.1k 0.7× 505 0.7× 285 0.8× 506 1.6× 186 0.6× 99 2.6k
Chian‐Shiu Chien Taiwan 25 1.5k 0.9× 710 1.0× 669 1.8× 151 0.5× 527 1.8× 57 2.8k
Gangqiao Zhou China 26 1.2k 0.7× 576 0.8× 602 1.7× 363 1.1× 254 0.9× 82 2.4k

Countries citing papers authored by Weijun Liu

Since Specialization
Citations

This map shows the geographic impact of Weijun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijun Liu more than expected).

Fields of papers citing papers by Weijun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijun Liu. The network helps show where Weijun Liu may publish in the future.

Co-authorship network of co-authors of Weijun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Weijun Liu. A scholar is included among the top collaborators of Weijun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijun Liu. Weijun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Feng, Wenjie You, Xiaoyu Wang, et al.. (2025). Core-shell ZIF-67/MoS2 heterojunction microneedle accelerates wound healing via enhanced photothermal nanozyme-like activities. Chemical Engineering Journal. 526. 171230–171230.
2.
Liu, Dan, Xiaolong Han, Juan Peng, et al.. (2024). Probiotics Combined with Metformin Improves Sperm Parameters in Obese Male Mice through Modulation of Intestinal Microbiota Equilibrium. Reproductive Sciences. 32(1). 116–130. 4 indexed citations
3.
4.
Zhang, Mingying, et al.. (2024). Effects of cell-free DNA on kidney disease and intervention strategies. Frontiers in Pharmacology. 15. 1377874–1377874. 2 indexed citations
5.
Liu, Weijun, Lihuan Zhang, Yutao Wang, et al.. (2023). hsa-mir-(4328, 4422, 548z and -628-5p) in diabetic retinopathy: diagnosis, prediction and linking a new therapeutic target. Acta Diabetologica. 60(7). 929–942. 3 indexed citations
6.
Yang, Jun, Yuan Liu, Yu Zhang, et al.. (2021). PGE2-JNK signaling axis non-canonically promotes Gli activation by protecting Gli2 from ubiquitin-proteasomal degradation. Cell Death and Disease. 12(7). 707–707. 9 indexed citations
7.
8.
Liu, Weijun, et al.. (2017). Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma. Cancer Letters. 394. 65–75. 44 indexed citations
9.
Markovina, Stephanie, Songyan Wang, Lauren E. Henke, et al.. (2017). Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer. British Journal of Cancer. 118(1). 72–78. 55 indexed citations
10.
Hu, Ling, Junmei Ai, Hui Long, et al.. (2016). Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Oncotarget. 7(8). 8441–8454. 46 indexed citations
11.
He, Xin, et al.. (2013). In vitro–in vivocorrelations for three different commercial immediate-release indapamide tablets. Drug Development and Industrial Pharmacy. 40(12). 1670–1676. 13 indexed citations
12.
Liu, Weijun, et al.. (2013). Rational design of microRNA–siRNA chimeras for multifunctional target suppression. RNA. 19(12). 1745–1754. 10 indexed citations
13.
Zhao, Jibin, et al.. (2012). A Robust Recognition Algorithm for Encoded Targets in Close-range Photogrammetry. Journal of information science and engineering. 28(2). 407–418. 9 indexed citations
14.
15.
Hu, Dong, Weijun Liu, George Y. Wu, & Yong Wan. (2011). Nuclear translocation of Skp2 facilitates its destruction in response to TGFβ signaling. Cell Cycle. 10(2). 285–292. 17 indexed citations
16.
Zhang, Liyong, Jing Wu, Hyun Kim, et al.. (2010). Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress. The EMBO Journal. 29(10). 1726–1737. 34 indexed citations
17.
Sun, Daekyu, Weijun Liu, Kexiao Guo, et al.. (2008). The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents. Molecular Cancer Therapeutics. 7(4). 880–889. 154 indexed citations
18.
Liu, Weijun, et al.. (2007). Cdh1-Anaphase-Promoting Complex Targets Skp2 for Destruction in Transforming Growth Factor β-Induced Growth Inhibition. Molecular and Cellular Biology. 27(8). 2967–2979. 42 indexed citations
19.
Qi, Jing, et al.. (2002). [Preliminary studies on the mechanisms of a new anti-tumor agent PH II-7 with special preference to multidrug resistant tumor cells].. PubMed. 24(2). 134–9. 4 indexed citations
20.
Liu, Weijun, et al.. (2002). Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochemical Pharmacology. 64(12). 1677–1687. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by César López‐Camarillo Breakdown of academic impact, for papers by Liwei Dong Breakdown of academic impact, for papers by Jingwan Zhang Breakdown of academic impact, for papers by Huizhe Huang Breakdown of academic impact, for papers by Ravindra Kolhe Breakdown of academic impact, for papers by Ninghan Feng Breakdown of academic impact, for papers by Ke Shi Breakdown of academic impact, for papers by Ji Eun Oh Breakdown of academic impact, for papers by Chian‐Shiu Chien Breakdown of academic impact, for papers by Gangqiao Zhou
Rankless by CCL
2026